English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
A lymphatic route for a hyperbranched heteroglycan from Radix Astragali to trigger immune responses after oral dosing Journal article
Zhang, Quanwei, Li, Lifeng, Hao, Shuang, Liu, Man, Huo, Chuying, Wu, Jianjun, Liu, Hongbing, Bao, Wanrong, Zheng, Hongming, Li, Zhipeng, Cheng, Huiyuan, Fung, Hauyee, Wong, Tinlong, Leung, Pingchung, Wang, Shunchun, Li, Ting, Zhang, Ge, Li, Min, Zhao, Zhongzhen, Jia, Wei, Bian, Zhaoxiang, Mitchison, Timothy, Zhang, Jingchao, Lyu, Aiping, Han, Quanbin, Sun, Handong. A lymphatic route for a hyperbranched heteroglycan from Radix Astragali to trigger immune responses after oral dosing[J]. Carbohydrate Polymers, 2022, 292.
Authors:  Zhang, Quanwei;  Li, Lifeng;  Hao, Shuang;  Liu, Man;  Huo, Chuying; et al.
Favorite | TC[WOS]:12 TC[Scopus]:15  IF:10.7/10.2 | Submit date：2023/01/30
Antitumor Immune Responses  Intact  Polysaccharide  Radix Astragali  Targeting Route  
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy Journal article
Jianjie Li, Xiaodong Shu, Jun Xu, Sek Man Su, Un In Chan, Lihua Mo, Jianlin Liu, Xin Zhang, Ragini Adhav, Qiang Chen, Yuqing Wang, Tingting An, Xu Zhang, Xueying Lyu, Xiaoling Li, Josh Haipeng Lei, Kai Miao, Heng Sun, Fuqiang Xing, Aiping Zhang, Chuxia Deng, Xiaoling Xu. S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy[J]. Nature Communications, 2022, 13(1), 1481.
Authors:  Jianjie Li;  Xiaodong Shu;  Jun Xu;  Sek Man Su;  Un In Chan; et al.
Favorite | TC[WOS]:40 TC[Scopus]:47  IF:14.7/16.1 | Submit date：2022/05/13
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer Journal article
Ping Chen, Xu Zhang, Renbo Ding, Linglin Yang, Xueying Lyu, Jianming Zeng, Josh Haipeng Lei, Lijian Wang, Jiong Bi, Nan Shao, Ditian Shu, Bin Wu, Jingbo Wu, Zhihui Yang, Haiyan Wang, Biqiong Wang, Kang Xiong, Yun Lu, Shaozhi Fu, Tak Kan Choi, Ng Wai Lon, Aiping Zhang, Dongyang Tang, Yingyao Quan, Ya Meng, Kai Miao, Heng Sun, Ming Zhao, Jiaolin Bao, Lei Zhang, Xiaoling Xu, Yanxia Shi, Ying Lin, Chuxia Deng. Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer[J]. Advanced Science, 2021, 8(22), 2101176.
Authors:  Ping Chen;  Xu Zhang;  Renbo Ding;  Linglin Yang;  Xueying Lyu; et al.
Favorite | TC[WOS]:88 TC[Scopus]:89  IF:14.3/16.3 | Submit date：2021/11/30
Advanced Breast Cancer  Drug Screening  Patient-derived Organoids  Personalized Therapy  
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation Journal article
Miao,Kai, Lei,Josh Haipeng, Valecha,Monica Vishnu, Zhang,Aiping, Xu,Jun, Wang,Lijian, Lyu,Xueying, Chen,Si, Miao,Zhengqiang, Zhang,Xin, Su,Sek Man, Shao,Fangyuan, Rajendran,Barani Kumar, Bao,Jiaolin, Zeng,Jianming, Sun,Heng, Chen,Ping, Tan,Kaeling, Chen,Qiang, Wong,Koon Ho, Xu,Xiaoling, Deng,Chu Xia. NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation[J]. Nature Communications, 2020, 11(1), 3256.
Authors:  Miao,Kai;  Lei,Josh Haipeng;  Valecha,Monica Vishnu;  Zhang,Aiping;  Xu,Jun; et al.
Favorite | TC[WOS]:63 TC[Scopus]:71  IF:14.7/16.1 | Submit date：2020/09/16